Manufacturer record
Laborate Pharmaceuticals India Ltd. III: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Laborate Pharmaceuticals India Ltd. III (Himachal Pradesh) was declared Not of Standard Quality in June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CXHDT5006, Ciprofloxacin HCl Tablets I.P (exp Mar 2028). SDFTL US Nagar,UK (state lab) found it not of standard quality: Description Rough surface on each Tablets. Listed in the June 2026 alert.
Records by type
1 record linked to Laborate Pharmaceuticals India Ltd. III in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ciprofloxacin HCl Tablets I.P | Batch CXHDT5006Mfg Apr 2025 · Exp Mar 2028 | Description Rough surface on each Tablets.Description | SDFTL US Nagar,UKState lab | Jun 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.